×
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)
QQQ   299.33 (+2.77%)
AAPL   143.78 (+2.32%)
MSFT   265.90 (+1.29%)
FB   191.63 (+4.24%)
GOOGL   2,155.85 (+1.88%)
AMZN   2,221.55 (+4.03%)
TSLA   707.73 (+7.43%)
NVDA   178.51 (+5.16%)
BABA   94.48 (+14.79%)
NIO   16.03 (+9.49%)
AMD   98.75 (+6.58%)
CGC   5.55 (+10.34%)
MU   70.60 (+4.02%)
T   21.32 (+0.09%)
GE   77.01 (+3.33%)
F   13.12 (+3.23%)
DIS   105.61 (+2.28%)
AMC   12.23 (+2.95%)
PFE   53.99 (+0.52%)
PYPL   80.42 (+0.37%)
NFLX   191.40 (+1.90%)

Beyond Air (XAIR) Stock Forecast, Price & News

$5.69
+0.05 (+0.89%)
(As of 05/26/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.42
$5.91
50-Day Range
$4.96
$7.83
52-Week Range
$4.62
$16.41
Volume
224,849 shs
Average Volume
248,539 shs
Market Capitalization
$169.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.4
30 days | 90 days | 365 days | Advanced Chart
Receive XAIR News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

Beyond Air logo

About Beyond Air

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Headlines

Beyond Air, Inc. (XAIR)
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:XAIR
Fax
N/A
Employees
41
Year Founded
N/A

Sales & Book Value

Annual Sales
$870 thousand
Book Value
$1.49 per share

Profitability

Net Income
$-22.88 million
Pretax Margin
-19,608.90%

Debt

Price-To-Earnings

Miscellaneous

Free Float
25,446,000
Market Cap
$169.74 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/11/2021
Today
5/26/2022
Next Earnings (Confirmed)
6/16/2022
Fiscal Year End
3/31/2023

MarketRank

Overall MarketRank

2.28 out of 5 stars

Medical Sector

286th out of 1,424 stocks

Surgical & Medical Instruments Industry

34th out of 137 stocks

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -













Beyond Air (NASDAQ:XAIR) Frequently Asked Questions

Is Beyond Air a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Beyond Air stock.
View analyst ratings for Beyond Air
or view top-rated stocks.

When is Beyond Air's next earnings date?

Beyond Air is scheduled to release its next quarterly earnings announcement on Thursday, June 16th 2022.
View our earnings forecast for Beyond Air
.

How can I listen to Beyond Air's earnings call?

Beyond Air will be holding an earnings conference call on Thursday, June 16th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) issued its quarterly earnings results on Thursday, November, 11th. The company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.28) by $0.08. During the same quarter in the prior year, the firm posted ($0.30) EPS.
View Beyond Air's earnings history
.

What price target have analysts set for XAIR?

4 analysts have issued 1-year target prices for Beyond Air's shares. Their forecasts range from $13.00 to $17.00. On average, they expect Beyond Air's stock price to reach $15.25 in the next twelve months. This suggests a possible upside of 168.0% from the stock's current price.
View analysts' price targets for Beyond Air
or view top-rated stocks among Wall Street analysts.

Who are Beyond Air's key executives?
Beyond Air's management team includes the following people:
  • Mr. Steven Adam Lisi, CEO & Chairman (Age 51, Pay $450k)
  • Mr. Amir Avniel, Co-Founder, Pres, COO & Director (Age 48, Pay $400k)
  • Mr. Douglas Quinton Larson, CFO, Principal Financial Officer & Principal Accounting Officer (Age 51)
  • Ms. Maria Yonkoski, Head of Investor Relations
  • Mr. Adam Newman, Chief Legal Officer & Gen. Counsel
  • Ms. Rebecca Van Doren, Head of Sales
  • Ms. Kori-Ann Taylor, Head of Marketing
  • Prof. Andrew R. Colin M.D., Chief Medical Officer & Member of Scientific Advisory Board
  • Dr. Giora Davidai M.D., Chief Medical Officer
  • Mr. Duncan Fatkin, Chief Commercial Officer
What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI).

What is Beyond Air's stock symbol?

Beyond Air trades on the NASDAQ under the ticker symbol "XAIR."

Who are Beyond Air's major shareholders?

Beyond Air's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.09%), BlackRock Inc. (0.89%), Renaissance Technologies LLC (0.51%), Goldman Sachs Group Inc. (0.41%), Advisor Group Holdings Inc. (0.32%) and NewEdge Advisors LLC (0.28%). Company insiders that own Beyond Air stock include Amir Avniel, Douglas Beck, Robert Carey, Ron Bentsur and Steven A Lisi.
View institutional ownership trends for Beyond Air
.

Which major investors are selling Beyond Air stock?

XAIR stock was sold by a variety of institutional investors in the last quarter, including Simplex Trading LLC, Cutler Group LP, Jane Street Group LLC, GSA Capital Partners LLP, Qube Research & Technologies Ltd, Goldman Sachs Group Inc., NewEdge Advisors LLC, and Advisor Group Holdings Inc.. Company insiders that have sold Beyond Air company stock in the last year include Amir Avniel, and Ron Bentsur.
View insider buying and selling activity for Beyond Air
or view top insider-selling stocks.

Which major investors are buying Beyond Air stock?

XAIR stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Kestra Advisory Services LLC, Group One Trading L.P., BlackRock Inc., Vanguard Group Inc., Charles Schwab Investment Management Inc., State Street Corp, and Meitav Dash Investments Ltd.. Company insiders that have bought Beyond Air stock in the last two years include Douglas Beck, Robert Carey, and Steven A Lisi.
View insider buying and selling activity for Beyond Air
or or view top insider-buying stocks.

How do I buy shares of Beyond Air?

Shares of XAIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Beyond Air's stock price today?

One share of XAIR stock can currently be purchased for approximately $5.69.

How much money does Beyond Air make?

Beyond Air has a market capitalization of $169.74 million and generates $870 thousand in revenue each year. The company earns $-22.88 million in net income (profit) each year or ($1.20) on an earnings per share basis.

How many employees does Beyond Air have?

Beyond Air employs 41 workers across the globe.

What is Beyond Air's official website?

The official website for Beyond Air is www.ait-pharm.com.

How can I contact Beyond Air?

Beyond Air's mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company can be reached via phone at (516) 665-8200.

This page was last updated on 5/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.